ABSTRACT
Objective To understand the dynamic variation of BMI and influencing factors among HIV/AIDS patients receiving highly active anti-retroviral therapy (HAART) in Liuzhou,Guangxi Zhuang Autonomous Region (Guangxi).Methods HIV/AIDS patients receiving HAART for the first time since 1 January 2013 were selected.Data on BMI was analyzed among patients receiving HAART at baseline,6 months and 12 months after treatment.By using the general linear model repeated measures of analysis of variance,BMI dynamic variations and influencing factors were described and analyzed.Results The average BMI of 2 871 patients at baseline,6th months and 12th months appeared as (20.65 ±3.32),(20.87 ± 3.22) and (21.18 ± 3.20),respectively,with differences all statistically significant (F=18.86,P＜0.001).BMI were increasing over time with treatments (F=37.25,P＜0.001).Main influencing factors were noticed as:age,sex,marital status,baseline data of CD4+T cells and the WHO classification on clinical stages.Conclusions Higher proportion of BMI malnutrition counts was seen among patients before receiving HAART in Liuzhou.BMI of the patients that were on HAART seemed being influenced by many factors.It is necessary to select appropriate treatment protocols on different patients so as to improve the nutritional status of the patients.
ABSTRACT
Objective To understand the dynamic variation of BMI and influencing factors among HIV/AIDS patients receiving highly active anti-retroviral therapy (HAART) in Liuzhou,Guangxi Zhuang Autonomous Region (Guangxi).Methods HIV/AIDS patients receiving HAART for the first time since 1 January 2013 were selected.Data on BMI was analyzed among patients receiving HAART at baseline,6 months and 12 months after treatment.By using the general linear model repeated measures of analysis of variance,BMI dynamic variations and influencing factors were described and analyzed.Results The average BMI of 2 871 patients at baseline,6th months and 12th months appeared as (20.65 ±3.32),(20.87 ± 3.22) and (21.18 ± 3.20),respectively,with differences all statistically significant (F=18.86,P＜0.001).BMI were increasing over time with treatments (F=37.25,P＜0.001).Main influencing factors were noticed as:age,sex,marital status,baseline data of CD4+T cells and the WHO classification on clinical stages.Conclusions Higher proportion of BMI malnutrition counts was seen among patients before receiving HAART in Liuzhou.BMI of the patients that were on HAART seemed being influenced by many factors.It is necessary to select appropriate treatment protocols on different patients so as to improve the nutritional status of the patients.
ABSTRACT
Objective To evaluate the correlation of the baseline clinical and laboratory test index with death,and to discuss the independent risk factors for long-term prognosis in elderly HIV/ AIDS patients who had accepted highly active antiretroviral therapy (HAART).Methods 1671 cases of HIV/AIDS patients were included in retrospective cohort study,divided into death group (183 cases) and non-death group (1488 cases) according to HIV/AIDS related death event,and followed up for 2 days to 120 months,an average of 427 days.Results During the period of followup,the proportion of male (12.45％) was higher than that of women (6.9％) in death group(x2 =10.42,P＜0.01).The mortality ratio of the WHO stage Ⅲ and Ⅳ was higher than that of the WHO stage Ⅰ and Ⅱ (x2 =18.67,P＜0.01).The mortality ratio was significantly higher in HIV/AIDS patients with baseline CD4+ T lymphocyte cell ＜100 cells/mm3 than ＞100 cells/mm3 (x2 =52.59,P＜0.01).The platelet (PLT),hemoglobin (HB),and blood glucose levels were lower in death group than in non-death group (P ＜ 0.05),but serum creatinine (SCR) and AST (aspartate aminotransferase) levels were higher than that in the non-death group (P＜0.05).There was no significantly differences between the death group and the non-death group in the index of white blood cell (WBC),blood urea nitrogen (BUN),total cholesterol (CH),triglyceride (TG),alanine aminotransferase (ALT) and total bilirubin (TB) levels (all P＞ 0.05).Multiple logistic regression analysis revealed that the WHO stage (OR=0.777,95％ CI:0.612～0.987,P＜0.05) and the baseline level of CD4+ T lymphocytes cell (OR=1.345,95％ CI:1.089～1.662,P＜0.01) were independent risk factors for long-term outcomes in elderly HIV/AIDS patients.Conclusions The WHO stage and baseline CD4+ T lymphocyte cell level are the independent risk factors for long-term prognosis in HIV/AIDS patients over 60 years of age.Early discovery and early beginning HAART can effectively improve the prognosis of elderly HIV/AIDS patients.